Life Sciences IP Litigation

Resolve high stakes disputes in the pharma, biotech and medical device sectors

Why Cooley

With a renowned life sciences practice, we play an instrumental role in the growth of many of the industry's most sophisticated companies

Combine technical knowledge with best in class trial advocacy    

Litigators with PhDs and master’s degrees across scientific disciplines

Seamless collaboration with Cooley’s patent prosecutors and life sciences lawyers

Integrated practices that offer deep experience in related areas such as antitrust laws and FDA/regulatory issues

Adept at breaking down complex scientific subject matter to educate and persuade judges and jurors

Decades of experience litigating Hatch-Waxman matters for branded pharmaceutical companies

Complete wins in commercially significant drug ownership and licensing disputes

Advise clients pre-litigation and in anticipation of product launches within the context of regulatory schemes

Leaders in IPR proceedings and strategies; top law firm for PTAB proceedings

Read more


Our Life Sciences Litigation webinar series has launched. Check out our first webinar, Learnings from 40 Years of Litigation Under the Hatch-Waxman Act.

Patent Strategy and Management Firm of the Year, Honoree

LMG Life Sciences, 2023


  • The American Lawyer: IP Litigation Department of the Year Finalist
  • LMG Life Sciences: EMEA Patent Litigation Firm of the Year: Biotech, Shortlist
  • Chambers: Nationwide: Intellectual Property
  • Legal 500 US: Patents - Litigation (full coverage) 
  • LMG Life Sciences: "Patent Strategy and Management Firm of the Year" Honoree
  • Managing IP: Patent Contentious, PTAB Litigation and Life Sciences "IP Star"
  • Patexia: Best Performing Law Firms for Patent Litigation

Capitalizing on lean staffing, Cooley has set itself apart with a recent trio of high-stakes trial victories

The American Lawyer